| 臺大學術典藏 |
2022-01-12T07:07:23Z |
Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
|
Lin C.-C.; Hsu Y.-C.; Li Y.-H.; Kuo Y.-Y.; HSIN-AN HOU; Lan K.-H.; Chen T.-C.; Tzeng Y.-S.; Kuo Y.-Y.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Chiu Y.-C.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice
|
Lin C.-C.; Yao C.-Y.; Hsu Y.-C.; HSIN-AN HOU; Yuan C.-T.; Li Y.-H.; Kao C.-J.; Chuang P.-H.; Chiu Y.-C.; Chen Y.; Chou W.-C.; Tien H.-F. |
| 國立成功大學 |
2022 |
Static and dynamic characteristics of rotary kiln reactor during processing of biomass and municipal solid waste
|
Lasek, J.;Głód, K.;Słowik, K.;Cygan, A.;Li, Y.-H. |
| 國立成功大學 |
2022 |
Treatment of Homozygous Familial Hypercholesterolemia (HoFH): A Case Series Study and Mini Review of PCSK9 Inhibitor for HoFH
|
Lin, J.-L.;Lee, P.-T.;Chen, P.-Y.;Cheng, K.-P.;Liu, Y.-W.;Liu, P.-Y.;Chao, T.-H.;Li, Y.-H. |
| 國立成功大學 |
2022 |
Mobilization of Hematopoietic Stem and Progenitor Cells during Dengue Virus Infection
|
Puc, I.;Ho, T.-C.;Chien, Y.-W.;Tan, S.-S.;Fong, Y.-C.;Chen, Y.-J.;Wang, S.-H.;Li, Y.-H.;Chen, Chen C.-H.;Chen, P.-L.;Perng, G.-C.;Tsai, J.-J. |
| 臺大學術典藏 |
2021-12-22T03:54:12Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
JIANN-SHING JENG; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; Wu C.-C.; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-12-22T03:54:04Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; JIANN-SHING JENG; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2021-12-22T03:53:55Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; JIANN-SHING JENG; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2021-12-22T03:53:53Z |
Comparison of the 2017 Taiwan lipid guidelines and the Western lipid guidelines for high risk patients
|
Li Y.-H.; Yeh H.-I.; JIANN-SHING JENG; Charng M.-J. |
| 臺大學術典藏 |
2021-11-26T05:56:35Z |
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
|
LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H. |
